Merck to stop clinical trial testing Keytruda with AstraZeneca's Lynparza in prostate cancer patientsMarket Watch • 03/15/22
SVB Leerink: AstraZeneca's Lynparza could bring in $9.7 billion in sales by 2028Market Watch • 03/14/22
LogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business UpdatesPRNewsWire • 03/04/22
Dow Jones Newswires: AstraZeneca Reports ‘Historic' Trial Results for Enhertu Cancer TreatmentMarket Watch • 02/22/22
AstraZeneca's Enhertu shown to improve survival in breast cancer patients in pivotal trialProactive Investors • 02/21/22